Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Räth

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicines|December 23, 2023
Exploring the Relationship between Plasma Adiponectin, Gender, and Underlying Diseases in Severe IllnessPatricia Mester, Ulrich Räth, Stephan Schmid, et al.
Biomedicines|December 23, 2023
Plasma Insulin-like Growth Factor-Binding Protein-2 of Critically Ill Patients Is Related to Disease Severity and SurvivalPatricia Mester, Ulrich Räth, Luisa Popp, et al.
International Journal of Molecular Sciences|December 23, 2023
Soluble CD137: A Potential Prognostic Biomarker in Critically Ill PatientsUlrich Räth, Patricia Mester, Herbert Schwarz, et al.
Biomedicines|May 25, 2024
Serum Adiponectin Predicts COVID-19 SeverityVlad Pavel, Ulrich Räth, Stephan Schmid, et al.
International Journal of Molecular Sciences|September 14, 2024
Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19Dennis Keller, Patricia Mester, Ulrich Räth, et al.
Viruses|July 27, 2024
High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19Patricia Mester, Dennis Keller, Claudia Kunst, et al.
Biomedicines|January 23, 2024
Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 SeverityPatricia Mester, Ulrich Räth, Stephan Schmid, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicines|December 23, 2023
Exploring the Relationship between Plasma Adiponectin, Gender, and Underlying Diseases in Severe IllnessPatricia Mester, Ulrich Räth, Stephan Schmid, et al.
Biomedicines|December 23, 2023
Plasma Insulin-like Growth Factor-Binding Protein-2 of Critically Ill Patients Is Related to Disease Severity and SurvivalPatricia Mester, Ulrich Räth, Luisa Popp, et al.
International Journal of Molecular Sciences|December 23, 2023
Soluble CD137: A Potential Prognostic Biomarker in Critically Ill PatientsUlrich Räth, Patricia Mester, Herbert Schwarz, et al.
Biomedicines|May 25, 2024
Serum Adiponectin Predicts COVID-19 SeverityVlad Pavel, Ulrich Räth, Stephan Schmid, et al.
International Journal of Molecular Sciences|September 14, 2024
Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19Dennis Keller, Patricia Mester, Ulrich Räth, et al.
Viruses|July 27, 2024
High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19Patricia Mester, Dennis Keller, Claudia Kunst, et al.
Biomedicines|January 23, 2024
Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 SeverityPatricia Mester, Ulrich Räth, Stephan Schmid, et al.
Pageof 1